- •Urinary tract infection is a major cause for hospitalisation in patients with MS.
- •Hospitalised patients are older, have progressive MS and high disability levels.
- •A small number of patients account for a large proportion of hospital admissions.
- •Antibiotic resistance was more frequent in patients with multiple presentations.
- •Management should emphasise good bladder, catheter and general physical care.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Multiple Sclerosis and Related Disorders
- Urinary tract infections in multiple sclerosis.Mult. Scler. 2016; 22: 855-861https://doi.org/10.1177/1352458516633903
- Multiple cause of death analysis in multiple sclerosis: A population-based study.Neurology. 2020; 94: e820-e829https://doi.org/10.1212/WNL.0000000000008907
- Urinary tract infection in multiple sclerosis: closing an audit loop by co-design and innovation.Br. J. Neurosci. Nurs. 2019; 15: 20-27https://doi.org/10.12968/bjnn.2019.15.1.20
- assessment and management | Guidance | NICE.Accessed December. 2019; 31
EAU Guidelines: Neuro-Urology | Uroweb. Accessed December31, 2019. https://uroweb.org/guideline/neuro-urology/.
- A UK consensus on the management of the bladder in multiple sclerosis.J. Neurol. Neurosurg. Psychiatry. 2009; 80: 470https://doi.org/10.1136/jnnp.2008.159178
- Urological Infections | Uroweb.Accessed December. 2019; 31
- Lower urinary tract infections: management, outcomes and risk factors for antibiotic re-prescription in primary care.E Clin. Med. 2019; 14: 23-31https://doi.org/10.1016/j.eclinm.2019.07.012
- Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction.Arch. Phys. Med. Rehabil. 2002; 83: 129-138https://doi.org/10.1053/apmr.2002.26605
- Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.Lancet Infect. Dis. 2018; 18: 957-968https://doi.org/10.1016/S1473-3099(18)30279-2
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Kidney and Transplant Group, ed. Cochrane Database of Systematic Reviews. Published online April 23, 2008. doi:10.1002/14651858.CD005131.pub2.
- Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: A study of 149 cases.Arch. Phys. Med. Rehabil. 1998; 79: 255-257https://doi.org/10.1016/S0003-9993(98)90003-X
- The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control.Spinal Cord. 2010; 48: 784-790https://doi.org/10.1038/sc.2010.32
- A risk prediction model of urinary tract infections for patients with neurogenic bladder.Int. J. Neurosci. 2020; 0: 1-9https://doi.org/10.1080/00207454.2020.1732973
- Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review.World J. Urol. 1999; 17: 308-315https://doi.org/10.1007/s003450050152
- Effect of L-Methionine on the risk of phosphate stone formation.Urology. 2016; 98: 39-43https://doi.org/10.1016/j.urology.2016.08.007
- Botulinum toxin a detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.Eur. Urol. 2008; 53: 613-619https://doi.org/10.1016/j.eururo.2007.08.039
- Effectiveness of preanalytic practices on contamination and diagnostic accuracy of urine cultures: a laboratory medicine best practices systematic review and meta-analysis.Clin. Microbiol. Rev. 2016; 29: 105-147https://doi.org/10.1128/CMR.00030-15
- UTIs in patients with neurogenic bladder.Curr. Urol. Rep. 2014; 15: 433https://doi.org/10.1007/s11934-014-0433-2
Neuro Response. Accessed January15, 2020. http://neuroresponse.com/.